TY - JOUR
T1 - Suramin is a novel activator of PP5 and biphasically modulates S100-activated PP5 activity
AU - Yamaguchi, Fuminori
AU - Yamamura, Sho
AU - Shimamoto, Seiko
AU - Tokumitsu, Hiroshi
AU - Tokuda, Masaaki
AU - Kobayashi, Ryoji
N1 - Funding Information:
Acknowledgments This research was supported by the Kagawa University Characteristic Prior Research Fund 2011. We are grateful to Keiko Tsurumi (Kagawa University) for their technical assistance.
PY - 2014/1
Y1 - 2014/1
N2 - Suramin is an activator of ryanodine receptors and competitively binds to the calmodulin-binding site. In addition, S100A1 and calmodulin compete for the same binding site on ryanodine receptors. We therefore studied the effects of suramin on protein phosphatase 5 (PP5) and S100-activated PP5. In the absence of S100 proteins, suramin bound to the tetratricopeptide repeat (TPR) domain of PP5 and activated the enzyme in a dose-dependent manner. In the presence of S100A2/Ca2+, lower concentrations of suramin dose-dependently inhibited PP5 activity as an S100 antagonist, whereas higher concentrations of suramin reactivated PP5. Although the C-terminal fragment of heat shock protein 90 (HspC90) also weakly activated PP5, the binding site of suramin and HspC90 may be different, and addition of suramin showed no clear effect on the phosphatase activity of PP5. Similar biphasic effects of suramin were observed with S100A1-, S100B- or S100P-activated PP5. However, the inhibitory effects of lower concentrations of suramin on S100A6-activated PP5 are weak and high concentrations of suramin further activated PP5. SPR and the cross-linking study showed inhibition of the interaction between S100 protein and PP5 by suramin. Our results revealed that suramin is a novel PP5 activator and modulates S100-activated PP5 activity by competitively binding to the TPR domain.
AB - Suramin is an activator of ryanodine receptors and competitively binds to the calmodulin-binding site. In addition, S100A1 and calmodulin compete for the same binding site on ryanodine receptors. We therefore studied the effects of suramin on protein phosphatase 5 (PP5) and S100-activated PP5. In the absence of S100 proteins, suramin bound to the tetratricopeptide repeat (TPR) domain of PP5 and activated the enzyme in a dose-dependent manner. In the presence of S100A2/Ca2+, lower concentrations of suramin dose-dependently inhibited PP5 activity as an S100 antagonist, whereas higher concentrations of suramin reactivated PP5. Although the C-terminal fragment of heat shock protein 90 (HspC90) also weakly activated PP5, the binding site of suramin and HspC90 may be different, and addition of suramin showed no clear effect on the phosphatase activity of PP5. Similar biphasic effects of suramin were observed with S100A1-, S100B- or S100P-activated PP5. However, the inhibitory effects of lower concentrations of suramin on S100A6-activated PP5 are weak and high concentrations of suramin further activated PP5. SPR and the cross-linking study showed inhibition of the interaction between S100 protein and PP5 by suramin. Our results revealed that suramin is a novel PP5 activator and modulates S100-activated PP5 activity by competitively binding to the TPR domain.
KW - Hsp90
KW - Protein phosphatase 5
KW - S100 protein
KW - Suramin
KW - Tetratricopeptide repeat
UR - http://www.scopus.com/inward/record.url?scp=84894478771&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84894478771&partnerID=8YFLogxK
U2 - 10.1007/s12010-013-0522-6
DO - 10.1007/s12010-013-0522-6
M3 - Article
C2 - 24068474
AN - SCOPUS:84894478771
SN - 0273-2289
VL - 172
SP - 237
EP - 247
JO - Applied Biochemistry and Biotechnology - Part A Enzyme Engineering and Biotechnology
JF - Applied Biochemistry and Biotechnology - Part A Enzyme Engineering and Biotechnology
IS - 1
ER -